Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;87(10):3721-3736.
doi: 10.1111/bcp.14825. Epub 2021 May 3.

Hypertension: Current trends and future perspectives

Paul G Hunter  1 , Fiona A Chapman  1 , Neeraj Dhaun  1
Affiliations

Hypertension: Current trends and future perspectives

Paul G Hunter et al. Br J Clin Pharmacol. 2021 Oct.

Abstract

Hypertension is a significant and increasing global health issue. It is a leading cause of cardiovascular disease and premature death worldwide due to its effects on end organs, and through its associations with chronic kidney disease, diabetes mellitus and obesity. Despite current management strategies, many patients do not achieve adequate blood pressure (BP) control. Hypertension-related cardiovascular mortality rates are rising in tandem with the increasing global prevalence of chronic kidney disease, diabetes mellitus and obesity. Improving BP control must therefore be urgently prioritised. Strategies include utilising existing antihypertensive agents more effectively, and using treatments developed for co-existing conditions (such as sodium-glucose cotransporter 2 inhibitors for diabetes mellitus) that offer additional BP-lowering and cardiovascular benefits. Additionally, novel therapeutic agents that target alternative prohypertensive pathways and that offer broader cardiovascular protection are under development, including dual angiotensin receptor-neprilysin inhibitors. Nonpharmacological strategies such as immunotherapy are also being explored. Finally, advancing knowledge of the human genome and molecular modification technology may usher in an exciting new era of personalised medicine, with the potential to revolutionise the management of hypertension.

Keywords: diabetes; hypertension; kidney disease; treatments.

PubMed Disclaimer

References

REFERENCES

    1. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
    1. WHO. Hypertension. World Health Organisation. https://www.who.int/news-room/fact-sheets/detail/hypertension. Published 2019. Accessed 2 October 2020.
    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-223.
    1. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959-968.
    1. Cuspidi C, Valerio C, Sala C, et al. Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure. Blood Press Monit. 2008;13(1):7-13.

Publication types

MeSH terms

Substances